Efficacy, Safety, and Systemic Exposure of Once-Daily Indacaterol Acetate in Pediatric Asthma: A Randomized, Double-Blind, Controlled Dose-Finding Study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Efficacy, Safety, and Systemic Exposure of Once-Daily Indacaterol Acetate in Pediatric Asthma: A Randomized, Double-Blind, Controlled Dose-Finding Study ; volume:43 ; number:9 ; day:8 ; month:9 ; year:2023 ; pages:719-728 ; date:9.2023
Clinical drug investigation ; 43, Heft 9 (8.9.2023), 719-728, 9.2023
- Urheber
-
Sekerel, Bulent Enis
Nell, Haylene
Laki, Istvan
Pak, Tatiana
Contreras, Edgar
Kolarz, Adam
D’Andrea, Peter
Manga, Volkan
Jain, Monish
Vaidya, Soniya
Valentin, Michele
Sen, Biswajit
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40261-023-01300-8
- URN
-
urn:nbn:de:101:1-2023121212011416278709
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:32 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Sekerel, Bulent Enis
- Nell, Haylene
- Laki, Istvan
- Pak, Tatiana
- Contreras, Edgar
- Kolarz, Adam
- D’Andrea, Peter
- Manga, Volkan
- Jain, Monish
- Vaidya, Soniya
- Valentin, Michele
- Sen, Biswajit
- SpringerLink (Online service)
Ähnliche Objekte (12)
Comparison of Once-Daily Bromfenac 0.07% Versus Once-Daily Nepafenac 0.3% in Patients Undergoing Phacoemulsification
Dose-finding evaluation of once-daily treatment with olodaterol, a novel long-acting β2-agonist, in patients with asthma: results of a parallel-group study and a crossover study
An open-label extension of a phase 2 dose-finding study of once-weekly somatrogon vs. once-daily Genotropin in children with short stature due to growth hormone deficiency: results following 5 years of treatment
Response-adaptive dose-finding under model uncertainty
Optimal dose‐finding for efficacy–safety models
Revisiting dose-finding of monoclonal antibodies in migraine
Dose-Finding Designs: The Role of Convergence Properties
Once weekly paclitaxel associated with a fixed dose of oral metronomic cyclophosphamide: a dose-finding phase 1 trial
O413 Pharmacokinetics (PK) of once-daily etravirine (ETR) without and with once-daily darunavir/ritonavir (DRV/r) in antiretroviral-naïve HIV-1 infected adults
Dose-finding studies in drug development for rare genetic diseases
Stereotactic body radiotherapy of adrenal metastases - a dose‐finding study
Stereotactic body radiotherapy of adrenal metastases — a dose‐finding study
Comparison of Once-Daily Bromfenac 0.07% Versus Once-Daily Nepafenac 0.3% in Patients Undergoing Phacoemulsification
Dose-finding evaluation of once-daily treatment with olodaterol, a novel long-acting β2-agonist, in patients with asthma: results of a parallel-group study and a crossover study
An open-label extension of a phase 2 dose-finding study of once-weekly somatrogon vs. once-daily Genotropin in children with short stature due to growth hormone deficiency: results following 5 years of treatment
Response-adaptive dose-finding under model uncertainty
Optimal dose‐finding for efficacy–safety models
Revisiting dose-finding of monoclonal antibodies in migraine
Dose-Finding Designs: The Role of Convergence Properties
Once weekly paclitaxel associated with a fixed dose of oral metronomic cyclophosphamide: a dose-finding phase 1 trial
O413 Pharmacokinetics (PK) of once-daily etravirine (ETR) without and with once-daily darunavir/ritonavir (DRV/r) in antiretroviral-naïve HIV-1 infected adults
Dose-finding studies in drug development for rare genetic diseases
Stereotactic body radiotherapy of adrenal metastases - a dose‐finding study
Stereotactic body radiotherapy of adrenal metastases — a dose‐finding study
Comparison of Once-Daily Bromfenac 0.07% Versus Once-Daily Nepafenac 0.3% in Patients Undergoing Phacoemulsification
Dose-finding evaluation of once-daily treatment with olodaterol, a novel long-acting β2-agonist, in patients with asthma: results of a parallel-group study and a crossover study
An open-label extension of a phase 2 dose-finding study of once-weekly somatrogon vs. once-daily Genotropin in children with short stature due to growth hormone deficiency: results following 5 years of treatment
Response-adaptive dose-finding under model uncertainty
Optimal dose‐finding for efficacy–safety models
Revisiting dose-finding of monoclonal antibodies in migraine
Dose-Finding Designs: The Role of Convergence Properties
Once weekly paclitaxel associated with a fixed dose of oral metronomic cyclophosphamide: a dose-finding phase 1 trial
O413 Pharmacokinetics (PK) of once-daily etravirine (ETR) without and with once-daily darunavir/ritonavir (DRV/r) in antiretroviral-naïve HIV-1 infected adults
Dose-finding studies in drug development for rare genetic diseases
Stereotactic body radiotherapy of adrenal metastases - a dose‐finding study